NCT00277082 Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung Status COMPLETED Phase N/A
NCT00276588 Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00275132 Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00274898 Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT00268489 Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00265785 S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00264602 Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT00264420 Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation Status COMPLETED Phase PHASE1
NCT00260871 Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications Status UNKNOWN Phase N/A
NCT00257179 The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor Status UNKNOWN Phase N/A
NCT00253591 Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00248495 Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00248482 Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00245154 Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00242983 Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer Status UNKNOWN Phase N/A
NCT00238628 A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00238615 Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC Status TERMINATED Phase PHASE2